Wound dressing and method for controlling severe, life-threatening bleeding
View Patent ↗This invention is directed to advanced hemorrhage control wound dressings, and methods of using and producing same. The subject wound dressing is constructed from a non-mammalian material for control of severe bleeding. The wound dressing for controlling severe bleeding is formed of a biomaterial comprising chitosan, a hydrophilic polymer, a polyacrylic polymer or a combination thereof. The kind of severe, life-threatening bleeding contemplated by this invention is typically of the type not capable of being stanched when a conventional gauze wound dressing is applied with conventional pressure to the subject wound. The wound dressing being capable of substantially stanching the flow of the severe life-threatening bleeding from the wound by adhering to the wound site, to seal the wound, to accelerate blood clot formation at the wound site, to reinforce clot formation at the wound site and prevent bleed out from the wound site, and to substantially prohibit the flow of blood out of the wound site.
1. A wound dressing comprising a compressed composite sponge comprising a freeze-dried and heat-compressed structure comprising a chitosan biomaterial having a density, after being heat-compressed, of between about 0.14 g/cm 3 to about 0.6 g/cm 3 , the freeze-dried and heat-compressed structure being sized and configured for shaping by hand for insertion into a wound site into contact with tissue for hemorrhage control, the freeze-dried and heat-compressed structure having a degree of adhesion to the wound site of about 40 kPa to about 500 kPa to adhere to tissue in the presence of blood flow and stanch bleeding within the wound site.
2. A wound dressing according to claim 1 , wherein the compressed composite sponge has a degree of adhesion to the wound site of about 60 kPa to about 250 kPa.
3. A wound dressing according to claim 1 , wherein the compressed composite sponge has a degree of adhesion to the wound site of about 100 kPa to about 200 kPa.
4. A wound dressing according to claim 1 , wherein the chitosan biomaterial has a pH of not more than about 5.5 when bleeding is stanched.
5. A wound dressing according to claim 1 , wherein the chitosan biomaterial has a pH of not more than about 4.5 when bleeding is stanched.
6. A wound dressing according to claim 1 , wherein the chitosan biomaterial has a pH of not more than about 4.0 when bleeding is stanched.
7. A wound dressing according to claim 1 , wherein the chitosan biomaterial comprises an acid selected from the group consisting of acetic acid, formic acid, lactic acid, ascorbic acid, hydrochloric acid, and citric acid.